2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.24) by 54.17 percent. This is a 66.67 percent increase over losses of $(1.11) per share from the same period last year. The company reported quarterly sales of $2.926 which missed the analyst consensus estimate of $12.293 million by 100.00 percent. This is a 100.00 percent decrease over sales of $10.684 million the same period last year.